MXPA01011045A - Sistema sustituto basado en celulas y metodo para evaluar la actividad de la proteasa ns3 de virus de la hepatitis c. - Google Patents

Sistema sustituto basado en celulas y metodo para evaluar la actividad de la proteasa ns3 de virus de la hepatitis c.

Info

Publication number
MXPA01011045A
MXPA01011045A MXPA01011045A MXPA01011045A MXPA01011045A MX PA01011045 A MXPA01011045 A MX PA01011045A MX PA01011045 A MXPA01011045 A MX PA01011045A MX PA01011045 A MXPA01011045 A MX PA01011045A MX PA01011045 A MXPA01011045 A MX PA01011045A
Authority
MX
Mexico
Prior art keywords
protease
cell
hcv
activity
polyprotein
Prior art date
Application number
MXPA01011045A
Other languages
English (en)
Spanish (es)
Inventor
Charles Pellerin
Original Assignee
Boehringer Ingelheim Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Ltd filed Critical Boehringer Ingelheim Ltd
Publication of MXPA01011045A publication Critical patent/MXPA01011045A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/04Fusion polypeptide containing a localisation/targetting motif containing an ER retention signal such as a C-terminal HDEL motif
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/50Fusion polypeptide containing protease site
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
MXPA01011045A 1999-05-04 2000-05-01 Sistema sustituto basado en celulas y metodo para evaluar la actividad de la proteasa ns3 de virus de la hepatitis c. MXPA01011045A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13236099P 1999-05-04 1999-05-04
PCT/CA2000/000496 WO2000066623A2 (en) 1999-05-04 2000-05-01 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease

Publications (1)

Publication Number Publication Date
MXPA01011045A true MXPA01011045A (es) 2002-07-22

Family

ID=22453660

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011045A MXPA01011045A (es) 1999-05-04 2000-05-01 Sistema sustituto basado en celulas y metodo para evaluar la actividad de la proteasa ns3 de virus de la hepatitis c.

Country Status (14)

Country Link
US (3) US7276373B2 (https=)
EP (1) EP1177211B1 (https=)
JP (1) JP4782927B2 (https=)
AT (1) ATE386746T1 (https=)
AU (1) AU772386B2 (https=)
CA (1) CA2365262C (https=)
DE (1) DE60038113T2 (https=)
DK (1) DK1177211T3 (https=)
ES (1) ES2300262T3 (https=)
HU (1) HUP0200945A3 (https=)
IL (2) IL145376A0 (https=)
MX (1) MXPA01011045A (https=)
NZ (1) NZ515861A (https=)
WO (1) WO2000066623A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2365262C (en) * 1999-05-04 2008-06-10 Boehringer Ingelheim (Canada) Ltd. Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
AU5920400A (en) * 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Cell-based assay systems for examining hcv ns3 protease activity
US6986892B1 (en) 1999-11-24 2006-01-17 Chiron Corporation Immunogenic Hepatitis C virus non-structural polypeptides
WO2001038360A2 (en) * 1999-11-24 2001-05-31 Chiron Corporation Novel hcv non-structural polypeptide
US6921634B2 (en) * 1999-12-23 2005-07-26 Board Of Regents, The University Of Texas System Replication competent hepatitus C virus and methods of use
CA2370803A1 (en) * 2000-02-25 2001-08-30 Cambridge Drug Discovery, Ltd. Methods for identifying a protease inhibitor
MXPA03005638A (es) 2000-12-22 2004-04-05 Boehringer Ingelheim Ca Ltd Auto replicacion de la molecula de arn de virus de la hepatitis c.
DE10234418A1 (de) * 2002-07-29 2004-02-12 Bayer Ag Verfahren zur Untersuchung und Beurteilung von Virusenzymen im HTS
EP1670415A4 (en) * 2003-09-12 2007-12-05 Vertex Pharma ANIMAL MODEL FOR STUDYING PROTEASES ACTIVITY AND HEPATIC DISORDERS
WO2005037214A2 (en) 2003-10-14 2005-04-28 Intermune, Inc. Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication
MX2008001166A (es) 2005-07-25 2008-03-18 Intermune Inc Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
AU2006301966A1 (en) 2005-10-11 2007-04-19 Array Biopharma, Inc. Compounds and methods for inhibiting hepatitis C viral replication
EP2392589A3 (en) 2005-11-11 2012-06-20 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
US7705138B2 (en) 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
WO2013027217A1 (en) * 2011-08-22 2013-02-28 Ramot At Tel-Aviv University Ltd. Zymoxins and methods of using the same
US9353423B2 (en) 2012-11-07 2016-05-31 Gilead Sciences, Inc. HCV genotype 6 replicons
US20210087548A1 (en) * 2017-07-24 2021-03-25 The Board Of Trustees Of The Leland Stanford Junior University Compositions and Methods for Inducing Protein Function
WO2022094463A1 (en) * 2020-11-02 2022-05-05 Regents Of The University Of Minnesota Live cell assay for protease inhibition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3269642B2 (ja) * 1990-06-25 2002-03-25 財団法人阪大微生物病研究会 非A非B型肝炎ウイルス遺伝子cDNAおよび抗原ポリペプチド
AU652941B2 (en) * 1990-06-25 1994-09-15 Research Foundation For Microbial Diseases Of Osaka University, The Non-A, Non-B hepatitis virus particles
US5861267A (en) * 1995-05-01 1999-01-19 Vertex Pharmaceuticals Incorporated Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity
IT1277914B1 (it) * 1995-08-22 1997-11-12 Angeletti P Ist Richerche Bio Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
KR100209095B1 (ko) * 1996-06-28 1999-07-15 성재갑 C형 간염 바이러스의 프로테아제의 활성을 측정할 수 있는 c형 간염 대체 바이러스, 그 재조합 유전자 및 그 용도
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
US6117639A (en) * 1998-08-31 2000-09-12 Vertex Pharmaceuticals Incorporated Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
CA2365262C (en) * 1999-05-04 2008-06-10 Boehringer Ingelheim (Canada) Ltd. Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease

Also Published As

Publication number Publication date
JP4782927B2 (ja) 2011-09-28
ES2300262T3 (es) 2008-06-16
DE60038113D1 (de) 2008-04-03
IL145376A (en) 2009-09-01
DE60038113T2 (de) 2009-02-12
EP1177211A2 (en) 2002-02-06
HUP0200945A2 (en) 2002-08-28
IL145376A0 (en) 2002-06-30
EP1177211B1 (en) 2008-02-20
NZ515861A (en) 2004-08-27
WO2000066623A3 (en) 2001-03-22
US20050227226A1 (en) 2005-10-13
WO2000066623A2 (en) 2000-11-09
CA2365262C (en) 2008-06-10
US7276373B2 (en) 2007-10-02
US7838207B2 (en) 2010-11-23
DK1177211T3 (da) 2008-06-02
CA2365262A1 (en) 2000-11-09
US20030162168A1 (en) 2003-08-28
HUP0200945A3 (en) 2004-07-28
US20030162169A1 (en) 2003-08-28
AU4282500A (en) 2000-11-17
ATE386746T1 (de) 2008-03-15
AU772386B2 (en) 2004-04-29
JP2002542812A (ja) 2002-12-17

Similar Documents

Publication Publication Date Title
CA2365262C (en) Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease
CA2079105C (en) Hepatitis c virus protease
CA2498653C (en) Inhibitor-resistant hcv ns3 protease
IL123248A (en) Preparations containing a section of HCV NS3 Helix
HUP0302593A2 (hu) Önállóan replikálódó RNS molekula hepatitis C vírusból
AU716379B2 (en) Methodology to produce, purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease
AU2002218906A1 (en) Self-replicating RNA molecule from hepatitis C virus
EP1102992A1 (en) Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease
Kim et al. In vivo determination of substrate specificity of hepatitis C virus NS3 protease: genetic assay for site-specific proteolysis
JP3878132B2 (ja) 精製活性型hcvns2/3プロテアーゼ
IE911130A1 (en) Hepatitis c protease inhibitors
US6803214B1 (en) Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
WO1999067376A1 (en) Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides

Legal Events

Date Code Title Description
FG Grant or registration